Long‐Term Correction of Murine Glycogen Storage Disease Type III by AAV‐Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial PullulanaseKuo An Liao, Baodong Sun|Advances in Cell and Gene Therapy|2025Cited by 1